Altrova Health to Host Investor Q&A Session on Tuesday, October 20 at 10:00 A.M. ET
Altrova Health (ATVHF) will host a live investor question-and-answer session to discuss its first U.S. sale of O-Spray.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Altrova Health (ATVHF) will host a live investor question-and-answer session to discuss its first U.S. sale of O-Spray. The session is scheduled for October 20, 2026, at 10:00 a.m. ET. Management will discuss the sale of 2,000 units, announced on October 19, and respond to general shareholder and investor inquiries. Participants can submit questions during the session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - October 20, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today reminds shareholders and investors that it will host a live question-and-answer (Q&A) session on Tuesday, October 20, 2026 at 10:00 a.m. ET.
Further to the Company's news release dated October 19, 2026, announcing the first U.S. sale of 2,000 units of its O-Spray™ product, management will discuss the announcement and respond to general inquiries from shareholders and investors.
How to Join
Participants can join the session by clicking here.
Shareholders and investors are encouraged to join a few minutes early. Questions can be submitted during the session.
About Altrova Health Inc.
Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment and wellness. The Company's strategy is focused on assembling products, technologies and strategic capabilities designed to address evolving market needs and support long-term growth.
On behalf of the Board of Directors of Altrova Health Inc.
"Geoff Benic"
Geoff Benic, CEO
Media & Investor Contact:
Altrova Health Inc.
Email: info@altrovahealth.com
Geoff Benic, Chief Executive Officer
Email: geoff@altrovahealth.com
Phone: +1 647-880-7314
Website: www.altrovahealth.com
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward-looking statements: This news release may contain forward-looking statements, including statements regarding the timing and content of the Q&A session. Such statements are subject to risks and uncertainties, and actual events may differ materially. Please refer to the Company's news release dated October 19, 2026 for the Cautionary Note Regarding Forward-Looking Statements and to the Company's filings on SEDAR+ at www.sedarplus.ca.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319927